Table 1. Demographics, clinical characteristics, and response to nasal Menopur administration | ||||||||
Participant number | Age (years) | Body mass index (kg/m2) |
Antral follicle count | Day 3 FSH (IU/mL) | Days of nasal Menopur intake | Peak FSH Level (IU/mL) | Peak estradiol level (pg/mL) | Size of largest follicle (mm) |
1 | 41 | 27.7 | 7 | 13 | 9 | 37.7 | 49 | 6.5 (on cycle day 13) |
2 | 34 | 29.2 | 17 | 6.0 | 8 | 10.0 | 94 | 10.5 (on cycle day 13) |
3 | 40 | 34.2 | 6 | 9.7 | 16 | 29.0 | 183 | 17 (on cycle day 20) |
4 | 35 | 26 | 12 | 3.4 | 8 | 15.7 | 90 | 10 (on cycle day 13) |